JW Lifescience Corporation (KRX:234080)

JW Lifescience Revenue

JW Lifescience had revenue of 63.25B KRW in the quarter ending June 30, 2026, with 1.58% growth. This brings the company's total for the last twelve months to 253.71B, up 4.13% year-over-year. In the year 2025, JW Lifescience had annual revenue of 257.83B with 15.89% growth. That makes JW Lifescience the 17,754th largest company in the world by revenue and 907th in South Korea.

• Revenue (ttm): 253.71B
• Revenue Growth: +4.13%
• P/S Ratio: 0.64
• Revenue / Employee: 854.23M
• Employees: 297
• Market Cap: 162.90B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicines 271.44B 95.4%
• Medical Devices 13.02B 4.6%

By Geography

Chart

• South Korea 241.94B 93.8%
• Export 15.04B 5.8%
• Unallocated 847.74M 0.3%

Fiscal year ended Dec 31, 2025 See the full JW Lifescience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	257.83B	35.35B	15.89%
Dec 31, 2024	222.48B	15.62B	7.55%
Dec 31, 2023	206.86B	17.93B	9.49%
Dec 31, 2022	188.93B	19.11B	11.26%
Dec 31, 2021	169.82B	-13.70B	-7.47%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error